Market Segmentation

The segment assessment of the Global Menopause Treatment Market is done by Treatment and Distribution Channels.

The treatment based segment of the menopause treatment market are non-hormonal treatment and hormonal treatment. The hormonal treatment segments are progesterone, estrogen, and combination. Hormonal treatments were largely prescribed over the years until, the effective non-hormonal treatments were introduced. The increase in the ability to non-hormonal treatment to alleviate menopausal symptoms, especially hot flashes and vaginal dryness can support the expansion of the menopause treatment market in the analysis period. The non-hormonal treatments are anti-depressants and others

The distribution channel based segments of the menopause treatment market are retail pharmacies, hospital pharmacies, and online stores. The hospital pharmacies segment can earn high revenue for the market across the analysis period. The segment can thrive at 6.59% CAGR in the analysis period. The increase in older women populace and surge in awareness and uptake about menopausal treatments can support the market expansion.

Regional Analysis

MRFR regional assessment of the menopause treatment market states that Americas market can secure the largest share of the worldwide market in the study period. The existence of renowned players in the US, along with rise in the uptake of hormonal therapy can prompt the expansion of the menopause treatment market in the review period. The easy of product clearances by different regulatory authorities can improve the expansion of the regional menopause treatment market in the review period.

In Europe, the menopause treatment market surge can be attribute to the increase in the adoption of menopause treatment solutions by the rising cases of urogenital complications and vasomotor symptoms observed in women. The presence of effective healthcare infrastructure base can also report the Europe market.

In Asia Pacific, the spreading awareness about women’s health can improve the regional market rise. In addition, the entry of new players and new tie-ups among regional distributors and vendors can impact the expansion of the market through the study period. 

Key Players 

Novo Nordisk A/S (Denmark), Allergan (Ireland), Pfizer Inc. (US), Novartis AG (Switzerland), Eli Lily and Company (US), Teva Pharmaceuticals (Israel), Emcure Pharmaceuticals Ltd (India), Cipla Inc. (India), Abbott Laboratories (US), and Merck & Co., Inc. (US) among others are some reputed companies that are functioning in the Menopause Treatment Market as enlisted by MRFR.

Industry News

August 2020

A study published by University Of Colorado School Of Medicine reveals that non-hormonal therapy can treat hot flashes and other type of menopause issues. The rise in application of modern non-hormonal solutions can support the market rise.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/menopause-treatment-market-4579